The Phospho-DDIT3 (Ser30) Antibody is a rabbit polyclonal antibody designed to detect the phosphorylated form of the DNA Damage-Inducible Transcript 3 (DDIT3) protein at serine residue 30. This antibody is widely used in molecular biology research to study cellular stress responses, particularly those involving endoplasmic reticulum (ER) stress and apoptosis. It is validated for applications such as Western blot (WB), immunohistochemistry (IHC), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) .
The DDIT3 protein, also known as CHOP (CCAAT/enhancer-binding protein homologous protein), functions as a transcription factor in the ER stress response pathway. Phosphorylation at Ser30 is a critical post-translational modification (PTM) that activates DDIT3, enabling its nuclear translocation and subsequent regulation of stress-inducible genes . The antibody specifically binds to this phosphorylated epitope, allowing researchers to monitor ER stress signaling and apoptosis in experimental models .
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| S14 | Phosphorylation | CSNK2A1 (CK2) | Uniprot |
| S30 | Phosphorylation | CSNK2A1 (CK2) | Uniprot |
| S31 | Phosphorylation | CSNK2A1 (CK2) | Uniprot |
| S49 | Phosphorylation | Uniprot | |
| T54 | Phosphorylation | Uniprot |
The antibody is extensively used to study ER stress-induced apoptosis. For example, it has been employed to detect DDIT3 activation in models of tunicamycin-induced ER stress . Its nuclear accumulation correlates with the induction of pro-apoptotic genes such as BBC3/PUMA and BCL2L11/BIM .
In studies of myxoid/round-cell liposarcomas (MLS/RCLS), the antibody has been used to investigate the oncogenic FUS-DDIT3 fusion protein. Research shows that FUS-DDIT3 recruits CDK2 to nuclear structures, altering its binding affinity and promoting aberrant cell cycle regulation .
Phospho-DDIT3 (Ser30) has been implicated in neurodegenerative diseases and metabolic disorders. It modulates inflammatory responses via caspase-11 activation and regulates endothelial nitric oxide synthase (NOS3) signaling in neovascularization .
St. John’s Labs: Anti-Phospho-DDIT3 (Ser30) Antibody (STJ91075) product datasheet.
Affinity Biosciences: Phospho-DDIT3/CHOP (Ser30) Antibody (AF3277) product information.
PMC2804592: DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS.
DDIT3 (DNA Damage-Inducible Transcript 3), also known as CHOP, CHOP10, GADD153, C/EBP zeta, and C/EBP-homologous protein, is a multifunctional transcription factor playing an essential role in the endoplasmic reticulum (ER) stress response. It functions as a critical mediator in response to a wide variety of cellular stresses and induces cell cycle arrest and apoptosis in response to ER stress . DDIT3 plays a dual role in cellular function, acting both as an inhibitor of CCAAT/enhancer-binding protein (C/EBP) function and as an activator of other genes. As a dominant-negative regulator, it dimerizes with members of the C/EBP family, impairs their association with C/EBP binding sites in promoter regions, and inhibits the expression of C/EBP regulated genes . Additionally, DDIT3 positively regulates the transcription of various stress-response genes, including TRIB3, IL6, IL8, IL23, TNFRSF10B/DR5, PPP1R15A/GADD34, BBC3/PUMA, BCL2L11/BIM, and ERO1L .
Phosphorylation of DDIT3/CHOP at Serine 30 represents a critical post-translational modification that regulates its protein stability and function. Recent research demonstrates that phosphorylation at Ser30 causes protein decay in the cytoplasm, reducing its total protein content and lowering the amount of CHOP that migrates to the nucleus . This phosphorylation is mediated by protein kinases such as casein kinase 2 alpha 1 (CSNK2A1) . The CHOP/phosphorylated CHOP ratio significantly changes during ER stress responses, with phosphorylated CHOP (Ser30) significantly increasing in response to certain treatments such as Sephin1, which has shown efficacy against neurodegenerative diseases . This phosphorylation event appears to be a key regulatory mechanism in determining cell fate during ER stress.
Several detection methods are available for studying Phospho-DDIT3 (Ser30):
Western Blotting (WB): Can be used to quantify total and phosphorylated DDIT3 levels in cell or tissue lysates .
Immunohistochemistry (IHC): Available for both paraffin-embedded (IHC-P) and frozen sections (IHC-F) of tissue samples .
Immunocytochemistry/Immunofluorescence (ICC/IF): Suitable for detecting subcellular localization of phosphorylated DDIT3 in cultured cells .
Enzyme-linked Immunosorbent Assay (ELISA): Particularly useful for detecting antigenic peptides .
For optimal results, researchers should determine appropriate antibody dilutions for each application based on their specific experimental conditions and sample types .
Phosphorylation of DDIT3/CHOP at Ser30 significantly impacts its nuclear translocation and subsequent transcriptional activity. Under normal conditions, CHOP is rarely found in the nucleus, but during ER stress (such as that induced by tunicamycin), CHOP can be recognized in approximately 60% of tubular cells in both cortex and medulla regions of kidney tissue . Research indicates that phosphorylation at Ser30 causes protein decay in the cytoplasm, which effectively reduces the total protein content available for nuclear translocation .
In experimental models using Sephin1 treatment, phosphorylated CHOP (Ser30) significantly increases while the percentage of nuclear CHOP decreases in both cortical and medullary regions, with a statistically significant decrease observed in the cortex . This suggests that Ser30 phosphorylation serves as a regulatory mechanism that controls CHOP's ability to translocate to the nucleus and activate transcription of cell death-related genes. The phosphorylation appears to create a negative feedback loop that limits CHOP's pro-apoptotic activities during prolonged ER stress, potentially providing cells with an opportunity to recover from stress before committing to apoptosis.
Designing robust experiments to investigate DDIT3 phosphorylation in ER stress models requires careful consideration of multiple factors:
ER Stress Induction Protocol:
Tunicamycin treatment (e.g., 2 mg/kg for in vivo studies) is commonly used to induce ER stress by inhibiting protein glycosylation and increasing misfolded protein accumulation .
Time course analyses are critical as ER stress pathways are highly dynamic, with each pathway showing unique temporal patterns of activation and resolution.
Sample Collection Timing:
For nuclear translocation studies, tissue harvesting at approximately 12 hours post-treatment is recommended since nuclear transfer of transcription factors occurs within minutes to hours in response to stimuli .
For phosphorylation status analysis, multiple time points should be evaluated as the phosphorylation state can rapidly change during the stress response.
Analytical Methods:
Subcellular Fractionation: Separate nuclear and cytoplasmic fractions to precisely monitor CHOP translocation.
Western Blotting: Use specific antibodies against total CHOP and phospho-CHOP (Ser30) to quantify relative phosphorylation levels.
Immunostaining: Calculate the positive rate of CHOP in the nucleus across different tissue regions to assess translocation efficiency .
Metabolic Profiling: Consider measuring cellular respiratory function and glycolysis using technologies such as the XFe96 extracellular flux analyzer to evaluate how CHOP phosphorylation affects cellular metabolism during ER stress .
Several potential artifacts and technical challenges may arise when detecting Phospho-DDIT3 (Ser30):
Antibody Specificity Issues:
Cross-reactivity with other phosphorylated residues on DDIT3 (such as S14, S15, S31, S49, T54) can occur .
Control experiments using phosphopeptide blocking should be conducted to ensure specificity, as demonstrated in published immunofluorescence and immunohistochemistry analyses .
Sample Preparation Considerations:
Rapid dephosphorylation by endogenous phosphatases during sample preparation can lead to false-negative results.
Phosphatase inhibitors must be included in all buffers during sample preparation.
Flash-freezing tissues immediately after collection is crucial to preserve phosphorylation status.
Temporal Dynamics:
The highly dynamic nature of ER stress pathways means phosphorylation status can change rapidly.
At later time points after stress induction, phosphorylated eIF2α (upstream of CHOP) may be lower in stressed cells than in control conditions as the stress response resolves .
This temporal complexity necessitates careful experimental design with multiple time points.
Detection Method Limitations:
Western blotting may not detect low levels of phosphorylated protein.
Immunostaining results can be influenced by fixation methods and antibody penetration issues.
Different detection methods may yield seemingly contradictory results due to differences in sensitivity and specificity.
The phosphorylation pattern of DDIT3 at Ser30 varies significantly depending on the specific cellular stressor:
ER Stress (Tunicamycin):
Tunicamycin treatment induces significant increases in total CHOP protein levels in various tissues, including renal tubular epithelial cells .
While total CHOP increases, the phosphorylation status at Ser30 appears to be dynamically regulated during the stress response.
Phosphatase Inhibition (Sephin1):
Treatment with Sephin1, originally identified as a protein phosphatase inhibitor, significantly increases phosphorylated CHOP at Ser30 while decreasing the CHOP/phosphorylated CHOP ratio compared to tunicamycin-treated groups .
This suggests that regulation of CHOP phosphorylation status may be a key mechanism by which Sephin1 exerts its protective effects against ER stress-induced cell death.
Kinase Activity:
Casein kinase 2 alpha 1 (CSNK2A1) has been identified as a kinase responsible for phosphorylating DDIT3 at multiple sites, including Ser30 .
Different stressors may activate distinct kinase pathways, leading to variations in the phosphorylation pattern.
Comparative Table of DDIT3 Phosphorylation Under Different Conditions:
| Condition | Total CHOP | Phospho-CHOP (Ser30) | CHOP/p-CHOP Ratio | Nuclear CHOP | Cellular Outcome |
|---|---|---|---|---|---|
| Control/Sham | Low | Very low | Variable | Rarely detected | Cell survival |
| Tunicamycin | Significantly increased | Increased | High | ~60% of cells positive | Apoptosis/cell death |
| Tunicamycin + Sephin1 | Decreased (vs. Tunicamycin alone) | Significantly increased | Significantly decreased | Reduced (significant in cortex) | Reduced cell death |
The relationship between DDIT3 Ser30 phosphorylation and the Integrated Stress Response (ISR) pathway is complex and involves multiple regulatory mechanisms:
ISR Pathway Components:
The ISR pathway initiates with the activation of stress-sensing kinases, including pancreatic ER kinase (PERK), which phosphorylates eIF2α. Phosphorylated eIF2α then attenuates general protein translation while selectively enhancing the translation of specific stress-response proteins, including ATF4, which subsequently induces CHOP expression .
Regulatory Feedback Loops:
While CHOP induction occurs downstream of eIF2α phosphorylation, the relationship between eIF2α phosphorylation and CHOP Ser30 phosphorylation appears to be indirect.
In experimental models, Sephin1 treatment affects CHOP Ser30 phosphorylation without significantly altering eIF2α phosphorylation status at certain time points .
This suggests that CHOP Ser30 phosphorylation may be regulated by pathways parallel to or downstream of the canonical ISR pathway.
Temporal Dynamics:
The ISR pathway exhibits complex temporal dynamics, with different components activated and inactivated at different time points.
By the time significant CHOP Ser30 phosphorylation is observed, eIF2α phosphorylation patterns may have already changed due to the dynamic nature of the stress response .
This temporal complexity makes it challenging to establish direct causal relationships between different components of the pathway.
Integration with Cell Death Pathways:
CHOP is a critical mediator of ER stress-induced cell death, and its nuclear translocation promotes the expression of pro-apoptotic genes.
Phosphorylation at Ser30 appears to regulate CHOP's activity by affecting its protein stability and nuclear translocation .
This suggests that CHOP Ser30 phosphorylation serves as a regulatory node integrating the ISR pathway with cell death execution mechanisms.
Preserving the phosphorylation status of DDIT3 at Ser30 requires careful sample preparation techniques:
Tissue Collection:
Rapid harvesting and immediate flash-freezing in liquid nitrogen are essential to prevent post-collection changes in phosphorylation status.
For in vivo studies, the timing of tissue collection is critical, as demonstrated in studies where kidneys were harvested 12 hours after treatment to capture nuclear translocation events .
Homogenization Buffer Composition:
Phosphatase inhibitors must be included in all buffers (e.g., PhosSTOP or equivalent).
Protease inhibitors (e.g., Protease Inhibitor Cocktail Set I) are essential to prevent protein degradation .
Standard fractionation buffer composition: 20 mM HEPES, 10 mM KCl, 2 mM MgCl₂, 1 mM EDTA, 1 mM EGTA, 1 M DTT, pH 7.2 .
Subcellular Fractionation Protocol:
Resuspend samples in fractionation buffer.
Homogenize by passing 20 times through a 29-gauge needle.
Maintain the lysate on ice for 20 minutes.
Separate nuclei by centrifugation at 720 × g for 5 minutes.
Further centrifuge supernatant at 12,000 × g for 10 minutes to separate cytoplasmic fraction.
Wash nuclear pellets with fractionation buffer and centrifuge at 720 × g for 10 minutes.
Resuspend and sonicate the nuclear pellet to shear genomic DNA and homogenize the lysate .
Protein Denaturation:
Immediate denaturation in SDS-containing buffer with heating is recommended for Western blotting applications to inactivate phosphatases.
For immunostaining, rapid fixation with appropriate fixatives (paraformaldehyde for immunofluorescence, formalin for IHC) helps preserve phosphorylation status.
Validating the specificity of Phospho-DDIT3 (Ser30) antibodies is crucial for reliable experimental results:
Peptide Competition Assays:
Pre-incubate the antibody with the phosphopeptide used as immunogen.
Compare staining patterns between blocked and unblocked antibody conditions.
Evidence of specificity is demonstrated when the phosphopeptide treatment eliminates or significantly reduces the signal, as shown in published immunofluorescence analyses of A549 cells and immunohistochemistry analyses of human breast carcinoma tissue .
Phosphatase Treatment Controls:
Treat one sample set with lambda phosphatase prior to antibody application.
Loss of signal after phosphatase treatment confirms phospho-specificity.
Knockout/Knockdown Controls:
Use DDIT3/CHOP knockout or knockdown models as negative controls.
Absence of signal in these models confirms antibody specificity for DDIT3 rather than cross-reactivity with other proteins.
Multiple Antibody Validation:
Use antibodies from different sources/clones targeting the same phosphorylation site.
Consistent results across different antibodies increase confidence in specificity.
Induction of Phosphorylation:
Compare samples from conditions known to induce DDIT3 phosphorylation (e.g., tunicamycin treatment) with untreated controls.
Expected increases in signal under inducing conditions support antibody specificity.
Accurate quantification of DDIT3 Ser30 phosphorylation levels requires careful experimental design and appropriate analytical methods:
Western Blotting Quantification:
Load equal amounts of protein (15-30 μg) per lane.
Include loading controls (β-actin, GAPDH, or total protein staining).
Probe separate membranes or strip and reprobe for total DDIT3 and phospho-DDIT3 (Ser30).
Calculate the phospho-DDIT3/total DDIT3 ratio to normalize for changes in total protein expression.
Use appropriate statistical analyses to evaluate significance of observed changes .
Immunofluorescence Quantification:
Capture multiple random fields per sample using consistent exposure settings.
Measure fluorescence intensity in relevant cellular compartments (nucleus vs. cytoplasm).
Count the percentage of cells with nuclear CHOP localization.
Use automated image analysis software for unbiased quantification .
Flow Cytometry:
Prepare single-cell suspensions from tissues or cultured cells.
Perform fixation and permeabilization to allow antibody access to intracellular epitopes.
Stain with fluorophore-conjugated Phospho-DDIT3 (Ser30) antibodies.
Analyze using flow cytometry to quantify the proportion of cells with positive staining and the intensity of staining.
Mass Spectrometry:
Enrich for phosphopeptides using techniques such as immobilized metal affinity chromatography (IMAC) or titanium dioxide (TiO₂) chromatography.
Perform liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis.
Quantify phosphorylated peptides relative to non-phosphorylated counterparts using label-free or labeled quantification methods.
DDIT3 Ser30 phosphorylation plays a significant role in renal pathology during ER stress-induced kidney injury:
Pathological Mechanisms:
In tunicamycin-induced ER stress models, renal damage is a frontline pathology, with tubular epithelial cell death being the primary manifestation .
CHOP is significantly increased by tunicamycin treatment in kidney tissue, contributing to cell death pathways.
The phosphorylation status of CHOP at Ser30 appears to regulate its ability to induce cell death, with increased phosphorylation potentially serving as a protective mechanism.
Protective Effects of CHOP Ser30 Phosphorylation:
Treatment with Sephin1, which increases CHOP Ser30 phosphorylation, reduces tunicamycin-induced renal damage .
The increased phosphorylation of CHOP at Ser30 correlates with decreased nuclear translocation of CHOP in renal tubular cells.
This decreased nuclear presence of CHOP is associated with reduced expression of cell death-related genes and improved cell survival.
Cellular Localization Patterns:
In sham-treated animals, CHOP is rarely found in the nucleus of renal tubular cells.
ER stress induced by tunicamycin results in nuclear localization of CHOP in approximately 60% of tubular cells in both cortex and medulla.
Sephin1 treatment, which increases CHOP Ser30 phosphorylation, decreases the percentage of cells with nuclear CHOP, with a significant decrease observed specifically in the cortex .
Potential Therapeutic Implications:
Modulating CHOP Ser30 phosphorylation could represent a novel therapeutic approach for protecting against ER stress-induced kidney injury.
Understanding the molecular mechanisms regulating CHOP phosphorylation may lead to the development of more targeted interventions for acute kidney injury and other ER stress-related renal diseases.
DDIT3 Ser30 phosphorylation appears to play a significant role in neurodegenerative disease models, though research in this area is still evolving:
Protective Mechanisms in Neurodegeneration:
Sephin1, which affects CHOP Ser30 phosphorylation, has demonstrated efficacy against neurodegenerative diseases in various models .
The protection of neurons from excitotoxicity by Sephin1 has been reported in some studies, though the exact mechanisms remain under investigation.
ER Stress in Neurodegeneration:
ER stress is a common feature across multiple neurodegenerative diseases, including Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS).
CHOP induction and nuclear translocation contribute to neuronal death in these conditions.
Regulation of CHOP Ser30 phosphorylation potentially provides a mechanism to modulate neuronal survival under ER stress conditions.
Integrated Stress Response (ISR) Modulation:
The ISR pathway, which includes CHOP as a downstream effector, has been implicated in various neurodegenerative conditions.
While some studies suggest that Sephin1's neuroprotective effects occur through ISR modulation, others indicate these effects may be independent of the canonical ISR pathway .
This discrepancy highlights the complex and potentially context-dependent role of CHOP Ser30 phosphorylation in neuronal stress responses.
Therapeutic Potential:
Understanding the regulatory mechanisms controlling CHOP Ser30 phosphorylation could lead to the development of more targeted neuroprotective strategies.
The ability to modulate CHOP's pro-apoptotic activities through phosphorylation represents a promising approach for intervening in neurodegenerative disease progression.
DDIT3/CHOP undergoes multiple post-translational modifications (PTMs) that work in concert to regulate its function:
Multiple Phosphorylation Sites:
DDIT3 contains several known phosphorylation sites, including S14, S15, S30, S31, S49, and T54 .
Many of these sites are phosphorylated by the same kinase, Casein Kinase 2 Alpha 1 (CSNK2A1), suggesting coordinated regulation .
Hierarchical Phosphorylation Patterns:
Current research suggests that phosphorylation at different sites may occur in a specific sequence or hierarchy.
Phosphorylation at one site may enhance or inhibit subsequent phosphorylation at other sites, creating complex regulatory patterns.
This hierarchical pattern may allow for fine-tuned control of CHOP activity in response to varying levels of cellular stress.
Functional Consequences of Multi-site Phosphorylation:
Different phosphorylation patterns likely result in distinct functional outcomes:
Some phosphorylation events may primarily affect protein stability
Others may regulate nuclear-cytoplasmic shuttling
Still others may directly impact DNA binding or transcriptional activity
Combinations of phosphorylation events may have synergistic or antagonistic effects
Other Post-translational Modifications:
Beyond phosphorylation, CHOP may undergo additional PTMs such as ubiquitination and acetylation.
These modifications may interact with phosphorylation events to create a complex "PTM code" that determines CHOP's ultimate activity and fate in the cell.
Recent methodological advances have significantly enhanced our ability to study DDIT3 phosphorylation dynamics in live cells:
Phospho-specific Biosensors:
Genetically encoded fluorescent biosensors based on Förster resonance energy transfer (FRET) technology can detect phosphorylation events in real-time.
These biosensors typically consist of a phospho-binding domain, a substrate sequence containing the phosphorylation site of interest, and two fluorescent proteins capable of FRET.
Phosphorylation of the substrate sequence induces conformational changes that alter FRET efficiency, providing a readout of phosphorylation status.
Live-cell Imaging Techniques:
Advanced microscopy methods including spinning disk confocal microscopy, lattice light-sheet microscopy, and total internal reflection fluorescence (TIRF) microscopy provide improved spatial and temporal resolution for tracking phosphorylation events.
These techniques allow researchers to observe phosphorylation dynamics with subcellular resolution and minimal phototoxicity.
Mass Spectrometry-based Approaches:
Pulse-chase SILAC (Stable Isotope Labeling with Amino acids in Cell culture) combined with mass spectrometry allows quantitative analysis of phosphorylation kinetics.
Targeted mass spectrometry methods such as parallel reaction monitoring (PRM) provide sensitive detection of specific phosphopeptides.
Phosphoproteomics workflows with improved enrichment methods enable comprehensive analysis of phosphorylation events across the proteome.
Integrated Multi-omics Approaches:
Combining phosphoproteomics with transcriptomics and metabolomics provides a more comprehensive understanding of how DDIT3 phosphorylation integrates with broader cellular responses.
These integrated approaches help identify the upstream regulators and downstream effects of DDIT3 phosphorylation in different cellular contexts.